(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SDCORD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SDCORD

ST13

US500000079208840

Class

5

Filing

79208840

Registration

5332245

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

07/09/2026

Trademark type

Word

Nice classes

5

Filing date

03/30/2017

Registration date

11/14/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/31/2024

Last transaction

07/09/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

NL

Examiner

CORWIN, CHARLOTTE K

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Glycostem Therapeutics B.V.
IPD Therapeutics B.V.

Representatives

Michael M. Morris Woodard Emhardt Moriarty McNett & Henry LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cell products for treating cancercells for medical use in the field of immuno-oncology

Publications

History of USPTO decisions and trademark events.

32 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/09/2026

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

05/31/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

04/14/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

04/14/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/31/2025

C71T

CANCELLED SECTION 71

05/31/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/08/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/14/2022

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/24/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/13/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/20/2018

FIMP

FINAL DISPOSITION PROCESSED

02/20/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/14/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

11/14/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/29/2017

PUBO

PUBLISHED FOR OPPOSITION

08/29/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/09/2017

RFNT

REFUSAL PROCESSED BY IB

07/21/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/17/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/17/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/17/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/17/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/14/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/14/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/01/2017

RFRR

REFUSAL PROCESSED BY MPU

07/01/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/24/2017

CNRT

NON-FINAL ACTION WRITTEN

06/23/2017

DOCK

ASSIGNED TO EXAMINER

06/21/2017

MAFR

APPLICATION FILING RECEIPT MAILED

06/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/05/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/01/2017

Continuous trademark protection

Get notified about every new filing that threatens SDCORD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.